CING CING
Company Profile ↓Company Overview
CING (CING) is a publicly traded company listed on with a market capitalization of $35.82M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -11.94% |
| 6 Months: | -20.71% |
| 3 Months: | -0.80% |
| 1 Month: | -2.95% |
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)54.74 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 57.6% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | 3.71M | 4.65M | 6.00M | 5.59M | 7.92M |
| Operating Income | -1.33M | -1.42M | -15.28M | -5.01M | -4.05M | -3.97M | -3.85M | -6.36M | -5.75M | -2.95M | -3.21M | -3.28M | -3.71M | -4.65M | -6.00M | -5.59M | -7.92M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | -3.54M | -4.50M | -5.89M | -5.46M | -7.80M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | -3.85M | -4.79M | -7.34M | -6.27M | -9.31M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Net Income | -1.33M | -1.43M | -15.29M | -5.00M | -4.04M | -4.03M | -4.00M | -6.62M | -5.98M | -2.97M | -3.23M | -4.13M | -3.85M | -4.79M | -7.34M | -6.27M | -9.31M |
| Diluted EPS | - | - | - | - | -0.36 | -0.36 | -7.08 | -6.79 | -72.60 | -7.21 | -5.47 | -2.34 | -1.04 | -0.98 | -1.23 | -0.87 | -0.95 |
| R&D Expense | 562.52K | 793.59K | 5.79M | 2.76M | 2.18M | 2.12M | 2.13M | 4.46M | 3.92M | 1.81M | 1.88M | 1.43M | 2.22M | 2.70M | 2.85M | - | 2.18M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Operating Income | -7.08M | -20.68M | -17.50M | -22.76M | -15.64M | -19.94M |
| Net Income | -7.18M | -20.71M | -17.68M | -23.53M | -16.56M | -22.45M |
| Diluted EPS | - | - | -29.35 | -311.99 | -10.86 | -4.44 |
| R&D Expense | 5.09M | 8.41M | 9.00M | 15.49M | 9.45M | 9.77M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | - | 5.79M | - | 11.41M | 3.49M | 14.86M | 15.07M |
| Current Assets | - | - | - | 7.87M | 578.59K | 12.66M | 12.01M |
| Cash & Equivalents | - | 1.20M | - | 5.36M | 52.42K | 12.21M | 10.95M |
| Inventory | - | - | - | - | - | - | - |
| Receivables | - | - | - | 234.43K | 14.62K | 26.32K | 8.01K |
| Total Liabilities | - | 4.50M | - | 7.52M | 10.36M | 7.41M | 12.56M |
| Current Liabilities | - | 3.36M | - | 7.01M | 10.23M | 4.97M | 10.31M |
| Long Term Debt | - | - | - | - | - | 2.44M | 1.15M |
| Total Debt | - | - | - | 5.87M | 3.51M | 5.10M | 8.79M |
| Total Equity | 615.88K | 1.29M | - | 3.88M | -6.87M | 7.46M | 2.51M |
| Shares Outstanding | - | - | - | 47.12K | 97.29K | 3.40M | 7.25M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.81M | - | -15.88M | -15.03M | -18.45M | -17.25M |
| Investing Cash Flow | -384.17K | - | -152.65K | -224.10K | -211.80K | -162.14K |
| Financing Cash Flow | 7.97M | - | 4.90M | 9.95M | 30.82M | 16.15M |
| Capital Expenditure | -402.10K | - | -153.42K | -224.10K | -211.80K | -162.14K |
| Free Cash Flow | -7.21M | - | -16.04M | -15.26M | -18.66M | -17.41M |
| Net Change in Cash | - | - | -11.14M | -5.30M | 12.16M | -1.26M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - |
| Net Margin % | - | - | - | - | - | - |
| ROE % | -555.8% | - | -455.3% | 342.6% | -222.1% | -894.8% |
| ROCE % | -292.0% | - | -398.5% | 338.0% | -158.2% | -418.8% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CING
Why Is CING Stock Jumping Over 4% In Overnight Trading? - Stocktwits
<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxOMGRSRkZaMnB0ekwyWWlyS0d5c3lseWtLVHMycm1FTi0ySUpSdldSeU1Xdm1sR0FRVTh0X2R4bFRSLUVUNUk5clhrMkV2QnBGeXZQMEdqZTZwSVZwWnJJaTZjVEUyWS10MTlwSjBYRnVoTk1JZ0YtanBNNkFDcm5pb0RyU2xJNEo2Z21Ec1…
Here is Why Cingulate (CING) is One of the Best NASDAQ Growth Stocks to Buy and Hold Forever - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxQYzJRSlRLWWpNYXY3SnZ0anJWTEd1RHZCZXV4X2dQaVFqZzl3a0RqSVl6OW15dUZjVUxrUEk1QWlhWE1heFFmUS1oV0lRcXdHeW81aEFpUC1IRUVELXhIVEx3Q2FKNmxSU3Y1M21ib0FCalBjSVBwVURJNHdwSkw2N3JLNlN2d0RjbWFZQl…
Cingulate Inc. Revenue Breakdown – NASDAQ:CING - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTFBJUU84T1JPT194MW1wWkVwUF8yUGdPMDhGZ1FTcTlvM2Nhb284VHBmSERsWnhLRktfeGJ3c0NLYmxUYkhOLUJJVEl2R0JVZDBiWHBZNTQ4N2xTY2JPZHlyeDI1UDJRTG9jVlY3SUpFU3RoSnM4U3hF?oc=5" target="_blank">Cingula…
Cingulate ADHD drug faces FDA data request, no safety concerns cited - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxOYm9TU1FsY3NXZTN6V3hvbDlmRXo3TFRtSTRFeDdtTUhZb3NTejZaZzRZaUZhNFkwalNzUlk0TDF1b3hmd3NCLUpEX1ZmaHAtQ3NKZlMtUWV6SG9CRUlUenR3VnhocVhBTGpYeXd2dWgxUWEwbTZUeHRXVzJ4TjUxQ3FabTgxRzI2Z3R3Mj…
Micron Stock Tops Nasdaq 100 Weekly Gainers Amid Memory Chip Rally: Q2 Report This Week Is The Next Test - Stocktwits
<a href="https://news.google.com/rss/articles/CBMi-wFBVV95cUxNV2RPa1BLcDFCZzlzX2xka2xpVFBzNWdzUzloWDJjbGxhSGc5c0hTZHByNWhqSUFlRHBkZVFEaDVFSm9taWIwOGpPYkhrOXBwQ1dLZUdyYXIwa0VDbVRFeHY3TU1La3lPeE5iWU9IWlJsNVJseWR2S2F1WS1Tbk40RVFVZXlFNU96UzMxUW…
$CING stock is down 10% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNVndORXR0bG9uekc4OGRoU1NLUU56NU1maXZnenVNeEhVcU9IMTVWNmU2UFloMmFOS0JIcWxPR3RoXzhGLW5sb0JZeTJwbkIybDNVLXdGSlFsV091azZ0ZGMwYkVEVkhqY0FaM3RiWC1Oemk3ZlB5WGVab0FiRFRWLUxZVWVQUVJLSnZLWX…
CING — Frequently Asked Questions
What is the current share price of CING?
As of 2026-08-05 17:25 PDT, CING trades at $4.94 on NASDAQ/NYSE. Its 52-week range is $3.33 to $11.66.
What is the market capitalisation of CING?
CING has a market capitalisation of $35.82M on NASDAQ/NYSE.
What is the P/E ratio of CING?
CING trades at a trailing price-to-earnings (P/E) ratio of -1.11. Its price-to-book (P/B) ratio is 14.28.
Is CING a good stock to buy?
This page provides a data-driven analysis of CING, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.